Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label Genu recurvatum. Show all posts
Showing posts with label Genu recurvatum. Show all posts

Tuesday, July 26, 2016

Control of Stroke-Related Genu Recurvatum With Prolonged Timing of Dorsiflexor Functional Electrical Stimulation: A Case Study

You'll have to have your doctor translate. It seems they must have been paid for using big confusing words.
http://mobile.journals.lww.com/jnpt/_layouts/15/oaks.journals.mobile/articleviewer.aspx?year=2016&issue=07000&article=00008

Chantraine, Frédéric MD; Schreiber, Céline MSc; Kolanowski, Elisabeth MD; Moissenet, Florent PhD

Journal of Neurologic Physical Therapy
July 2016
Vol. 40 - Issue 3: p 209–215
CollapseFavoritePDF


Background and Purpose: Abnormal knee hyperextension during the stance phase (genu recurvatum) is a common gait abnormality in persons with hemiparesis due to stroke. While ankle-foot orthoses (AFOs) are often used to prevent genu recurvatum by maintaining ankle dorsiflexion during the stance phase, AFOs reduce ankle joint mobility. Functional electrical stimulation (FES) is an alternative to the use of AFO for producing appropriately timed ankle dorsiflexion and with prolonged timing may also have value for reducing genu recurvatum.
Case Description: A 51-year-old man with chronic stroke was the subject of this case study. The patient had excessive plantarflexion during stance phase (ie, dynamic equinus foot), with associated genu recurvatum.
Intervention: Evaluation included clinical examination, instrumented gait analysis, 10-meter walk test, and 6-minute walk test. The patient underwent a trial of botulinum toxin to the plantarflexor muscles that was not effective for controlling the genu recurvatum. A subsequent trial with surface FES to elicit dorsiflexion during gait was effective, and he subsequently received an implanted FES system.
Outcomes: Stimulation-induced contraction of the dorsiflexors during terminal swing phase resulted in improved ankle dorsiflexion at initial contact. Moreover, extension of stimulation into the loading phase ensured tibial advancement, which limited knee hyperextension. The patient was reevaluated 12 months following implantation with continued positive outcomes.
Discussion: This case study illustrates the potential value of prolonged timing of dorsiflexor FES to manage genu recurvatum attributed to a dynamic equinus foot in a stroke survivor.

Tuesday, November 18, 2014

Treatment strategies for Genu recurvatum in adult patients with hemiparesis: a case series

No idea on Genu recurvatum, that is what your doctor and therapists are supposed to know more about than you.
http://www.pmrjournal.org/article/S1934-1482%2814%2901474-9/abstract
, ,
Nisha Patel, MD1
,
Nancy Yeh, MD2
,
Ona Bloom, Ph.D3
,
Address where study conducted: Department of Physical Medicine and Rehabilitation The Hofstra North Shore Long Island Jewish health system 1554 Northern Blvd, 4th Floor Manhasset, New York 11030 TEL: 516-627-8470 FAX: 516-365-8941
1Current institutional affiliation: Adventist rehab hospital 9909 Medical center drive Rockville MD 20850
2Department of Physical Medicine and Rehabilitation The Hofstra North Shore Long Island Jewish health system 1554 Northern Blvd, 4th Floor Manhasset, New York 11030 TEL: 516-627-8470 FAX: 516-365-8941
3Assistant Investigator, The Feinstein Institute for Medical Research Assistant Professor, Dept. of Physical Medicine and Rehabilitation; Molecular Medicine The Hofstra North Shore-LIJ School of Medicine 350 Community Drive, Fl 2352 Manhasset, NY 11030 Tel: #516-562-3839
Publication stage: In Press Accepted Manuscript

Abstract

Objective

To report our clinical experience and propose a biomechanical factor-based treatment strategy for improvement of genu recurvatum (GR), in order to reduce the need for knee-ankle-foot orthosis (KAFO) or surgical treatment.

Design

Case series.

Setting

Outpatient clinic of a Department of Physical Medicine and Rehabilitation in an academic medical center.

Subjects and interventions

Adult subjects (n=22) with hemiparesis and GR who received Botulinium injections alone or in combination with multiple types of orthotic interventions that included solid AFO ± heel lift, hinged AFO with an adjustable posterior stop (APS) ± heel lift, AFO with dual-channel ankle joint ± heel lift or a knee AFO (KAFO) with offset knee joint. Biomechanical factors reviewed included muscle strength, modified Ashworth score (MAS) for spasticity, presence of clonus, posterior capsule laxity, sensory deficits and proprioception.

Outcome Measurements

Outcome factors were improvement or elimination of GR based on subjective assessment before and after the interventions by the same experienced clinician.

Results

More than one biomechanical factor contributed to GR in all patients. Botulinium toxin A injection was used in patients who had significant plantar flexor spasticity and/or clonus. Four types of orthotic interventions were used based on the biomechanical factor : solid AFO in patients with severe ankle dorsiflexion and plantar flexion weakness or clonus; hinged ankle joint with APS with less severe ankle dorsiflexion weakness in the absence of clonus; AFO with a dual-channel ankle joint for quadriceps weakness or severe proprioceptive deficits; KAFO with offset knee joints in Achilles tendon contracture or severe proprioceptive deficits. Adjunctive options included addition of heel lifts and to toe plate modifications. Combinatorial interventions of Botulinium injection, modified AFOs, and heel lifts improved or eliminated GR and avoided need for cumbersome orthotics or surgical interventions.

Conclusions

GR in hemiparesis is multifactorial and can be successfully controlled by a using a conservative biomechanical factor-based approach and using combined medical and orthotic interventions. A algorithmic approach and a prospective study design is proposed to determine a combination of effective interventions to correct GR.